# Aveanna Healthcare account plan

> Aveanna Healthcare is a US home care platform for medically complex patients, with about 32,000 employees in 38 states and FY2025 revenue of $2,433.2 million.

## At a glance

Aveanna Healthcare is a US home care platform for medically complex, high-cost patients and says it is the largest provider of private duty nursing (PDN) in the United States. It operates in 38 states with more than 1,500 payers and about 32,000 employees, and is paid mostly by Medicaid managed care organizations (58.7% of revenue) and state Medicaid (22.8%). In FY2025 (53 weeks to January 3, 2026) revenue was $2,433.2 million (+20.2%), Adjusted EBITDA $320.9 million and net income $225.0 million, including a $118.1 million tax benefit. The company is listed on Nasdaq, and its Sponsors can significantly influence its affairs.

## Business units

- **Private Duty Services (PDS)** (82% of FY2025 revenue ($2,001.1 million)): Private duty nursing and pediatric therapy for medically complex children and young adults, typically starting at discharge from a NICU or PICU, plus school nursing and day healthcare centres. FY2025 revenue rose 22.4% on more hours and a revenue rate of $43.39 per hour; Q3 2026 revenue was $574.2 million (+11.6%).
- **Home Health & Hospice (HHH)** (10% of FY2025 revenue ($248.6 million)): Home health, hospice and specialty programmes for predominantly elderly patients, paid mostly by Medicare and Medicare Advantage. FY2025 revenue rose 14.1% with a 54.0% gross margin; in Q3 2026 revenue was $72.1 million (+15.6%) with episodes up 24.0%.
- **Medical Solutions (MS)** (8% of FY2025 revenue ($183.5 million)): Enteral nutrition and respiratory supplies delivered to adults and children, with 24/7/365 clinical support. FY2025 revenue rose 6.6%; Q3 2026 revenue was $49.2 million (+9.1%) with unique patients served up 7.7%.

## Strategic priorities

- **Preferred payer partnerships**: Capacity is steered to payers paying enhanced rates: PDS has 38 preferred payers covering 65% of PDS MCO volumes, up from 57% at the end of 2025, with about 40 expected by year end.
- **State Medicaid rate wins**: There have been eight state rate enhancements in 2026; in California a PDN rate investment of about $60 million takes effect January 1st, 2027, and Aveanna is lobbying to make it permanent.
- **Acquisitions and geographic expansion**: More Family First-type acquisitions are planned for 2027, seven new PDS states are targeted, and Aveanna wants to become a semi-national, then national, home health provider.
- **Long-term organic growth targets**: Targets are PDS 5%-6%, Home Health and Hospice 8%-10% and Medical Solutions 8%-10%, aiming for double-digit total revenue growth with M&A.
- **Deleveraging**: Leverage is around four times, with a goal of sub 3x by mid to late 2027.
- **Technology, AI and cross-selling**: AI and automation is one of five strategic initiatives, alongside cross-selling enteral nutrition to PDN patients and reinvestment in platforms such as Workday, iCIMS and Brightree.

## Latest results

In Q3 2026 (quarter ended October 3, 2026) revenue rose 11.8% to $695.5 million, operating income was $83.6 million (12.0% of revenue) and net income $45.5 million against $14.1 million a year earlier. Adjusted EBITDA rose 25% to $100.1 million. For the nine months, revenue was $2,013.9 million (+13.7%) and operating cash flow $157.5 million. Management raised 2026 guidance to revenue greater than $2.695 billion and adjusted EBITDA greater than $374 million.

## Investments and deals

- **Family First acquisition**: Family First, a pediatric PDN provider with 27 locations in seven states, was acquired on June 1, 2026 for about $173.7 million in cash; integration should be mostly done by the end of Q4.
- **Thrive Skilled Pediatric Care**: Acquired June 2, 2025 for approximately $75.7 million including 11.2 million shares, adding 23 locations in seven states.
- **Debt refinancing and repricing**: Debt was refinanced in September 2025 and repriced in May 2026; indebtedness is $1,521.3 million at a 6.8% weighted average rate.
- **Technology platform**: Aveanna runs iCIMS for recruiting, CellTrak for visit verification, Netsmart myUnity, Homecare Homebase and Brightree for clinical records, and Workday for finance, payroll and HR.

## Challenges and risks

- **Clinician shortage**: Labor is the constraint: the industry faces a shortage of licensed clinicians, which raises labor costs; California fill rates are sub 50%.
- **Medicaid and Medicare funding**: The One Big Beautiful Bill Act is projected to cut federal Medicaid spending by about $1.15 trillion over ten years, and Medicare home health rates were cut 1.3% for CY2026.
- **Leverage**: Debt is substantial and variable-rate, and goodwill and intangibles are approximately 60% of total assets.
- **Cybersecurity and IT risk**: The 10-K lists cybersecurity, AI and IT-system risks.
- **Integration risk**: The 10-K flags acquisition integration risk as Aveanna absorbs Family First and plans more deals.

## What leadership says

> "our industry does not have a demand problem." — Jeff Shaner, President and Chief Executive Officer, Q3 2026 earnings call, November 12, 2026

> "We think the trough has happened, and we're starting the way back up in Home Health." — Jeff Shaner, President and Chief Executive Officer, Deutsche Bank 2026 Healthcare Summit, September 16, 2026

> "we really do not plan on slowing down" — Matt Buckhalter, Chief Financial Officer, Q3 2026 earnings call, November 12, 2026


## Where a supplier can help

- **Nurse recruiting and retention**: Tied to the clinician shortage challenge: recruiting, scheduling and engagement tools help add the capacity that management calls the constraint.
- **Payer data and reporting**: Tied to the preferred payer priority: data, outcomes reporting and value-based care analytics support the scale and reporting Aveanna sells to MCOs.
- **Acquisition integration**: Tied to the Family First acquisition and the M&A plan: systems conversion, data migration and back-office integration partners fit repeated deals.
- **AI and automation**: Tied to the AI and automation initiative: automation of revenue cycle, documentation and back-office work fits a strategic initiative management names.
- **Cybersecurity**: Tied to the cybersecurity risk: security providers protect clinical and payment systems across a 38-state footprint.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for fiscal year 2025 (ended January 3, 2026)](https://www.sec.gov/Archives/edgar/data/1832332/000119312526115851/avah-20260103.htm)

Annual report · 2026-03-19

- Aveanna is a US home care platform for medically complex, high-cost patients. It has locations in 38 states, more than 1,500 payers and about 32,000 employees, and says it is the largest provider of private duty nursing (PDN) in the United States.
- FY2025 (53 weeks to January 3, 2026): revenue $2,433.2 million (+20.2%), Adjusted EBITDA $320.9 million (vs $183.6 million) and net income $225.0 million, including a $118.1 million tax benefit.
- Segments: Private Duty Services is 82% of revenue ($2,001.1 million, +22.4%), Home Health & Hospice 10% ($248.6 million, +14.1%) and Medical Solutions 8% ($183.5 million, +6.6%).
- Payer mix: Medicaid MCO 58.7%, Medicaid 22.8%, Medicare 9.9% and Commercial 8.5%. Growth depends on state Medicaid rate increases and MCO contracts.
- Margins: gross margin rose to 33.3% from 31.4%, and Field contribution margin to 17.9% from 14.0%. PDS revenue per hour was up 11.4% to $43.39.
- M&A: Thrive Skilled Pediatric Care was acquired in June 2025 (23 locations), and an agreement to buy Family First for $175.5 million in cash was signed in March 2026 (27 locations in seven states).
- Strategy: share gain in existing markets, value-based care with MCO payers, tuck-in and expansion acquisitions, cross-selling enteral nutrition to PDN patients, and reinvestment in technology (Workday, iCIMS, Netsmart myUnity, Homecare Homebase, Brightree).
- Debt: refinanced in September 2025. Total indebtedness is $1,486.7 million, and the weighted average rate fell to 7.3% from 9.2%.
- Risks: clinician shortages and labor costs, Medicaid funding under the One Big Beautiful Bill Act (about $1.15 trillion of federal Medicaid cuts over ten years), Medicare home health rate cuts (-1.3% for CY2026), cybersecurity and AI, and leverage.

### [Form 10-Q for the third quarter of fiscal 2026 (ended October 3, 2026)](https://www.sec.gov/Archives/edgar/data/1832332/000119312526456866/avah-20261003.htm)

Interim report · 2026-11-12

- Q3 2026 revenue was $695.5 million (+11.8%), operating income $83.6 million (12.0% of revenue) and net income $45.5 million (vs $14.1 million).
- PDS revenue was $574.2 million (+11.6%): hours were up 10.2%, helped by Family First, and the revenue rate was up 1.4% to $44.09 per hour. Gross margin was 28.9%.
- Home Health & Hospice revenue was $72.1 million (+15.6%), with total episodes up 24.0%, episodic mix at 80.2% and gross margin at 53.3%.
- Medical Solutions revenue was $49.2 million (+9.1%), with unique patients served up 7.7% and gross margin at 45.2%.
- Nine months: revenue $2,013.9 million (+13.7%), net income $127.4 million and operating cash flow $157.5 million.
- Family First was acquired on June 1, 2026 for about $173.7 million in cash, funded from cash on hand.
- The credit facility was repriced in May 2026. Indebtedness is $1,521.3 million at a 6.8% weighted average rate, and caps hedge $1,400.0 million notional.
- J.H. Whitney affiliates and other holders sold 15,000,000 shares in an August 2026 secondary offering; the company received no proceeds.

### [Aveanna Q3 2026 earnings call transcript](https://stockanalysis.com/stocks/avah/transcripts/732670-q3-2026/)

Executive talk · Jeff Shaner, President and Chief Executive Officer · 2026-11-12

- Q3 revenue was $695.5 million (+11.8%) and adjusted EBITDA $100.1 million (+25%). 2026 guidance was raised to revenue greater than $2.695 billion and adjusted EBITDA greater than $374 million.
- Shaner: "our industry does not have a demand problem". Labor was the constraint, and capacity is now steered to preferred payers that pay enhanced rates.
- PDS has 38 preferred payers, expected to reach about 40 by year end. They account for 65% of PDS MCO volumes, up from 57% at the end of 2025. There have been eight state rate enhancements in 2026.
- California: a PDN rate investment of about $60 million (state plus CMS match) takes effect January 1st, 2027. Aveanna is fighting to make it permanent before passing base wage increases to nurses.
- Home Health: episodic mix is 80%, episodes are up 24% and there are 52 episodic agreements year to date. Medical Solutions has 22 preferred payers and growth "in the high single digits".
- Long-term organic growth targets: PDS 5%-6%, Home Health and Hospice 8%-10%, Medical Solutions 8%-10%, aiming for double-digit total revenue growth with M&A.
- Family First integration should be mostly done by the end of Q4, and more "Family First-type acquisitions" are planned for 2027. AI and automation is one of five strategic initiatives.

### [Aveanna at the Deutsche Bank 2026 Healthcare Summit (fireside chat transcript)](https://stockanalysis.com/stocks/avah/transcripts/740975-deutsche-bank-2026-healthcare-summit/)

Executive talk · Jeff Shaner, President and Chief Executive Officer · 2026-09-16

- Shaner and CFO Matt Buckhalter describe a turnaround since early 2023, built on allocating scarce caregiver capacity to "preferred" payers, now in "year four".
- PDS (about 80% of revenue): 37 preferred payer arrangements covering roughly 64% of volumes. Home Health: 50 episodic preferred agreements, 81% episodic and 15.5% organic growth.
- The long-range plan was re-underwritten with Capstone's 50-state analysis of the One Big Beautiful Bill Act. Pediatric PDN is "incredibly well-insulated", and the home health trough has passed.
- California: an estimated 1,000 to 1,400 children are unserved, fill rates are sub 50% against an ideal of 80%-85%, and there is a "two to three year growth algorithm" once the new rate lands.
- Expansion: seven new PDS states are targeted, with Tennessee and Ohio requested by payers. The goal is to be around a "40, 41 state Medicaid provider".
- M&A: Aveanna wants to become a semi-national, then national, home health and hospice provider, buying home health rather than hospice at 13-15x multiples.
- Leverage is around four times; the goal is "sub 3x" by mid to late 2027. EBITDA margin is expected "between high thirteens and kind of mid to high fourteens".

## Questions about Aveanna Healthcare

### What does Aveanna Healthcare do?

Aveanna provides home care for medically complex, high-cost patients: private duty nursing for children and young adults, home health and hospice, and enteral nutrition and respiratory supplies.

### What is Aveanna's revenue?

FY2025 revenue was $2,433.2 million (+20.2%). For 2026 management guides to revenue greater than $2.695 billion.

### How many employees does Aveanna have?

About 32,000 employees in 38 states, according to the FY2025 10-K.

### Who leads Aveanna Healthcare?

Jeff Shaner is President and Chief Executive Officer and Matthew Buckhalter is Chief Financial Officer.

### What is Aveanna's strategy?

Steering caregiver capacity to preferred payers that pay enhanced rates, winning state rate increases, acquiring providers to expand into new states, and reducing leverage.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
